Class 2 medicines recall. Photo courtesy of @MHRAgovuk

The Medicines and Healthcare products Regulatory Agency (MHRA) has announced that two types of prescription-only Ranitidine medicines from Medley Pharma Limited are being recalled.

It said the pharma company was recalling all unexpired stock from pharmacies and retail stores as a precautionary measure.

Ranitidine 150mg and Ranitidine 300mg Tablets have been recalled due to possible contamination with an impurity N-nitrosodimethylamine which has genotoxic and carcinogenic potential.

MHRA had the following advice for healthcare professionals and wholesalers:

  1. Stop supplying the above products immediately and remove from the shelves within your store.
  2. Quarantine all remaining stock and return it to your supplier using your supplier’s approved process.
  3. If you receive queries about this issue from patients, advise them to contact their GP, pharmacist or healthcare professional to review ongoing treatment

 

If you want to share your stories and/or experiences with us, please send an email to editor@pharmacy.biz

LEAVE A REPLY